GLP-3

GLP-3 is a triple hormone agonist designed to activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. This multi-receptor activation enhances insulin secretion, suppresses appetite, increases energy expenditure and improves metabolic control, making it a promising candidate for obesity and type 2 diabetes management.